PD-L1 − targeted magnetic fluorescent hybrid nanoparticles: Illuminating the path of image-guided cancer immunotherapy.
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 50; no. 8; pp. 2240 - 2244 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jul2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=164176973&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 164176973 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 16197070 NPC jtl: European Journal of Nuclear Medicine & Molecular Imaging issn: 16197070 maglogo: N pubinfo: dt: Jul2023 vid: 50 iid: 8 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 164176973 162572397 10.1007/s00259-023-06202-7 164176973 ppf: 2240 ppct: 4 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: PD-L1 − targeted magnetic fluorescent hybrid nanoparticles: Illuminating the path of image-guided cancer immunotherapy. aug: au: Li, Xiaoyan Younis, Muhsin H. Wei, Weijun Cai, Weibo affil: Departments of Radiology and Medical Physics, University of WI – Madison, Madison, WI, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|